AdWTp53 transduction (NCI)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAdWTp53 transduction (NCI)
Drug Alias Nameoncolytic adenovirus therapy expressing human wild-type p53 protein (National Cancer Institute)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsLymphoma, Large-Cell, Anaplastic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsLymphoma, Large-Cell, Anaplastic

Other Information

ATC CodeN/A
Related LinksN/A